23 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Phosphate-modified analogues of m(7)GTP and m(7)Gppppm(7)G-Synthesis and biochemical properties.

University of Warsaw
Structure-activity relationship study of 4EGI-1, small molecule eIF4E/eIF4G protein-protein interaction inhibitors.

Harvard Medical School
Synthesis of rigidified eIF4E/eIF4G inhibitor-1 (4EGI-1) mimetic and their in vitro characterization as inhibitors of protein-protein interaction.

Harvard Medical School
Structure-guided design, synthesis, and evaluation of guanine-derived inhibitors of the eIF4E mRNA-cap interaction.

Amgen
Synthesis and evaluation of potential inhibitors of eIF4E cap binding to 7-methyl GTP.

University of Minnesota
Synthesis and properties of mRNA cap analogs containing imidodiphosphate moiety--fairly mimicking natural cap structure, yet resistant to enzymatic hydrolysis.

University of Warsaw
A collection of caged compounds for probing roles of local translation in neurobiology.

University of Toronto
Design, synthesis and evaluation of analogs of initiation factor 4E (eIF4E) cap-binding antagonist Bn7-GMP.

University of Minnesota
Phosphorothioate analogs of m7GTP are enzymatically stable inhibitors of cap-dependent translation.

University of Warsaw
Design of Cell-Permeable Inhibitors of Eukaryotic Translation Initiation Factor 4E (eIF4E) for Inhibiting Aberrant Cap-Dependent Translation in Cancer.

University of Michigan
Medicinal chemistry approaches to target the MNK-eIF4E axis in cancer.

Northwestern University
Design of nucleotide-mimetic and non-nucleotide inhibitors of the translation initiation factor eIF4E: Synthesis, structural and functional characterisation.

University of Nottingham
Inhibitors of Eukaryotic Translational Machinery as Therapeutic Agents.

Merck
Update on the Development of MNK Inhibitors as Therapeutic Agents.

A*Star
Progress in developing MNK inhibitors.

Ocean University of China and Laboratory For Marine Drugs and Bioproducts
A biphenyl inhibitor of eIF4E targeting an internal binding site enables the design of cell-permeable PROTAC-degraders.

Dana-Farber Cancer Institute
A cell-penetrant lactam-stapled peptide for targeting eIF4E protein-protein interactions.

University of Michigan
Exploring tryptamine conjugates as pronucleotides of phosphate-modified 7-methylguanine nucleotides targeting cap-dependent translation.

University of Warsaw
Consideration of Binding Kinetics in the Design of Stapled Peptide Mimics of the Disordered Proteins Eukaryotic Translation Initiation Factor 4E-Binding Protein 1 and Eukaryotic Translation Initiation Factor 4G.

University of Michigan
7-Methylguanosine monophosphate analogues with 5'-(1,2,3-triazoyl) moiety: Synthesis and evaluation as the inhibitors of cNIIIB nucleotidase.

University of Warsaw
Anchimerically Activated ProTides as Inhibitors of Cap-Dependent Translation and Inducers of Chemosensitization in Mantle Cell Lymphoma.

Mayo Clinic
Somatostatin receptor subtype 4 (SSTR4) agonists

Centrexion Therapeutics
Leflunomide's Bioactive Metabolite Has the Minimal Structural Requirements for the Efficient Inhibition of Human Dihydroorotate Dehydrogenase

Novartis Pharma